TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest announcement is out from Nasus Pharma Ltd. ( (NSRX) ).
Nasus Pharma Ltd., a company involved in the pharmaceutical industry, announced changes in its board of directors on September 3, 2025. Dan Teleman, the Chief Executive Officer, has been appointed as a Class III director, filling a vacancy on the board. His term will last until the annual general meeting of shareholders in 2028. Additionally, the board has replaced David Silberman with Ronnie Hershman on the Compensation Committee, indicating a strategic shift in its governance structure.
More about Nasus Pharma Ltd.
Average Trading Volume: 65,486
Find detailed analytics on NSRX stock on TipRanks’ Stock Analysis page.